Modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related diseases

Details for Australian Patent Application No. 2002244006 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors Kinney, Gene G.; Gribkoff, Valentin K.; Dworetzky, Steven; Hewawasam, Piyasena

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002244006

PCT Pub. Number WO2002/072088

Priority 60/269,967 20.02.01 US

Filing date 14 February 2002

Wipo publication date 24 September 2002

International Classifications

A61K 031/404

C07D 239/42 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 031/506 - not condensed and containing further heterocyclic rings

A61P 025/06 Drugs for disorders of the nervous system

C07D 209/34 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002244006

10 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002244007-IN-VIVO BLOOD STORAGE SYSTEM

2002244005-A METHOD AND SYSTEM FOR A LOW-OVERHEAD MOBILITY MANAGEMENT PROTOCOL IN THE INTERNET PROTOCOL LAYER